Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Cbonds API
Bring Market Data into Your Systems

Access ETF and Mutual Funds Data via API

  • Prices & NAV
  • Fund Structure
  • Inflows & dividends

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
156.87 USD
NAV per Share | 10/09/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
10,569.39 mln USD
Fund NAV | 10/09/2026
10,569.39 mln USD
Share Class NAV | 10/09/2026
No
UCITS
1 / 3 (11/09/2015)
Split
Included in the Free Plan
  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds

Start exploring global markets in less than 1 minute

  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Free Plan

Yield on 11/09/2026, NYSE Arca

  • YTD
    28.66 %
  • 1M
    -1.18 %
  • 3M
    17.78 %
  • 6M
    23.71 %
  • 1Y
    64.3 %
  • 3Y
    99.37 %
  • 5Y
    19.32 %
  • 10Y
    158.63 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 10/09/2026

Download structure in Excel
Paper Value
MODERNA INC 2.87%
TWIST BIOSCIENCE CORP 1.81%
HALOZYME THERAPEUTICS INC 1.47%
NATERA INC 1.46%
KYMERA THERAPEUTICS INC 1.45%
TRAVERE THERAPEUTICS INC 1.4%
ROIVANT SCIENCES LTD 1.39%
ORUKA THERAPEUTICS INC 1.38%
REVOLUTION MEDICINES INC 1.36%
PRAXIS PRECISION MEDICINES I 1.36%
INSMED INC 1.34%
PROTAGONIST THERAPEUTICS INC 1.33%
DIANTHUS THERAPEUTICS INC 1.31%
REGENERON PHARMACEUTICALS 1.27%
CG ONCOLOGY INC 1.27%
VAXCYTE INC 1.25%
SUMMIT THERAPEUTICS INC 1.23%
SCHOLAR ROCK HOLDING CORP 1.22%
ERASCA INC 1.16%
RELAY THERAPEUTICS INC 1.16%
RHYTHM PHARMACEUTICALS INC 1.15%
GILEAD SCIENCES INC 1.15%
TG THERAPEUTICS INC 1.15%
IOVANCE BIOTHERAPEUTICS INC 1.15%
SPYRE THERAPEUTICS INC 1.14%
VERTEX PHARMACEUTICALS INC 1.14%
SELLAS LIFE SCIENCES GROUP I 1.13%
ARROWHEAD PHARMACEUTICALS IN 1.13%
INCYTE CORP 1.13%
BIOMARIN PHARMACEUTICAL INC 1.13%
VIKING THERAPEUTICS INC 1.12%
ABBVIE INC 1.1%
AMGEN INC 1.09%
MADRIGAL PHARMACEUTICALS INC 1.09%
GRAIL INC 1.07%
BIOGEN INC 1.07%
ACADIA PHARMACEUTICALS INC 1.07%
KRYSTAL BIOTECH INC 1.07%
CYTOKINETICS INC 1.06%
EXELIXIS INC 1.06%
COGENT BIOSCIENCES INC 1.05%
BRIDGEBIO PHARMA INC 1.04%
UNIQURE NV 1.03%
MIRUM PHARMACEUTICALS INC 1.03%
CRISPR THERAPEUTICS AG 1.02%
ALKERMES PLC 1.02%
IMMUNOVANT INC 0.95%
NEUROCRINE BIOSCIENCES INC 0.94%
CELCUITY INC 0.94%
IMMUNITYBIO INC 0.94%
UNITED THERAPEUTICS CORP 0.89%
SAREPTA THERAPEUTICS INC 0.89%
PTC THERAPEUTICS INC 0.89%
VERA THERAPEUTICS INC 0.86%
VIRIDIAN THERAPEUTICS INC 0.85%
IDEAYA BIOSCIENCES INC 0.84%
ALNYLAM PHARMACEUTICALS INC 0.82%
MINERALYS THERAPEUTICS INC 0.8%
BEAM THERAPEUTICS INC 0.8%
BIOCRYST PHARMACEUTICALS INC 0.77%
CELLDEX THERAPEUTICS INC 0.75%
DYNE THERAPEUTICS INC 0.74%
IONIS PHARMACEUTICALS INC 0.73%
IMMUNOME INC 0.73%
DENALI THERAPEUTICS INC 0.72%
ADMA BIOLOGICS INC 0.71%
DISC MEDICINE INC 0.69%
NOVAVAX INC 0.68%
RECURSION PHARMACEUTICALS A 0.68%
HYPERLIQUID STRATEGIES 0.68%
INTELLIA THERAPEUTICS INC 0.67%
ARCUTIS BIOTHERAPEUTICS INC 0.66%
ARCUS BIOSCIENCES INC 0.66%
TANGO THERAPEUTICS INC 0.66%
AGIOS PHARMACEUTICALS INC 0.65%
SYNDAX PHARMACEUTICALS INC 0.64%
NURIX THERAPEUTICS INC 0.62%
VERACYTE INC 0.61%
PALVELLA THERAPEUTICS INC 0.6%
CAREDX INC 0.56%
ULTRAGENYX PHARMACEUTICAL IN 0.51%
VIR BIOTECHNOLOGY INC 0.51%
CULLINAN THERAPEUTICS INC 0.49%
KODIAK SCIENCES INC 0.48%
BIOHAVEN LTD 0.47%
PRECIGEN INC 0.46%
XENCOR INC 0.46%
STOKE THERAPEUTICS INC 0.45%
VERICEL CORP 0.44%
INHIBRX BIOSCIENCES INC 0.43%
ANAPTYSBIO INC 0.42%
ABSCI CORP 0.41%
ZENAS BIOPHARMA INC 0.41%
ORIC PHARMACEUTICALS INC 0.38%
VOR BIOPHARMA INC 0.38%
CORVUS PHARMACEUTICALS INC 0.37%
REPLIMUNE GROUP INC 0.35%
KURA ONCOLOGY INC 0.35%
FIRST TRACKS BIOTHERAPEUTICS 0.34%
AVALO THERAPEUTICS INC 0.34%
Show more Hide
Other - %
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.